Acute promyelocytic leukemia in 57 previously untreated patients
✍ Scribed by Catherine Cordonnier; Jean Paul Vernant; Bernard Brun; Michèle Gouault Heilmann; Mathieu Kuentz; Philippe Bierling; Jean Pierre Farcet; Martine Rodet; Nagib Duedari; Michèle Imbert; Hélène Jouault; Patrice Mannoni; Félix Reyes; Bernard Dreyfus; Henri Rochant
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 729 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Acute myeloid leukemia (AML) carries a dismal prognosis in older patients. In this study, the authors evaluated the safety and efficacy of arsenic trioxide combined with low‐dose cytarabine in untreated patients aged ≥60 years with AML. ## METHODS. In a phase 1/2 desig
## Abstract Sixteen children (ages 2–17) with acute promyelocytic leukemia (APL) were studied retrospectively. Diagnosis was based on clinical features and morphological criteria of the FAB classification. Bleeding diathesis was the predominant presenting symptom (>85%), associated with laboratory